Literature DB >> 20110600

Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome.

Antonia M W Coppus1, Heleen M Evenhuis, Gert-Jan Verberne, Frank E Visser, Piet Eikelenboom, Willem A van Gool, A Cecile J W Janssens, Cornelia M van Duijn.   

Abstract

In a prospective longitudinal cohort study of dementia and mortality in persons with Down syndrome aged 45 years and older, 85 postmenopausal women were followed for a mean follow-up time of 4.3 years (range 0.0 to 7.4 years). The effect of age at menopause on age at diagnosis of dementia and survival was estimated using correlation analysis and Cox Proportional Hazard Model. We found a significant correlation between age at menopause and age at diagnosis of dementia (rho=0.52; p< 0.001), and between age at menopause and age at death (rho=0.49; p=0.01). Early age at menopause is associated with a 1.8 fold increased risk of dementia: Hazard Ratio (HR): 1.82 (95%Confidence Interval (CI): 1.31-2.52) and with risk of death: HR: 2.05 (95%CI: 1.33-3.16). Our study suggests that age at menopause in women with Down syndrome is a determinant of age at onset of dementia and mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20110600     DOI: 10.3233/JAD-2010-1247

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

Review 1.  Estrogen-cholinergic interactions: Implications for cognitive aging.

Authors:  Paul Newhouse; Julie Dumas
Journal:  Horm Behav       Date:  2015-07-14       Impact factor: 3.587

2.  Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.

Authors:  Riley Bove; Elizabeth Secor; Lori B Chibnik; Lisa L Barnes; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neurology       Date:  2013-12-11       Impact factor: 9.910

Review 3.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

4.  Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?

Authors:  Carey E Gleason; N Maritza Dowling; Elliot Friedman; Whitney Wharton; Sanjay Asthana
Journal:  Menopause       Date:  2012-05       Impact factor: 2.953

5.  Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.

Authors:  Victor W Henderson; Roberta Diaz Brinton
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

6.  Gender and iron genes may modify associations between brain iron and memory in healthy aging.

Authors:  George Bartzokis; Po H Lu; Kathleen Tingus; Douglas G Peters; Chetan P Amar; Todd A Tishler; J Paul Finn; Pablo Villablanca; Lori L Altshuler; Jim Mintz; Elizabeth Neely; James R Connor
Journal:  Neuropsychopharmacology       Date:  2011-03-09       Impact factor: 7.853

Review 7.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Authors:  Rebecca A Nebel; Neelum T Aggarwal; Lisa L Barnes; Aimee Gallagher; Jill M Goldstein; Kejal Kantarci; Monica P Mallampalli; Elizabeth C Mormino; Laura Scott; Wai Haung Yu; Pauline M Maki; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2018-06-12       Impact factor: 21.566

Review 8.  Estrogen synthesis and signaling pathways during aging: from periphery to brain.

Authors:  Jie Cui; Yong Shen; Rena Li
Journal:  Trends Mol Med       Date:  2013-01-22       Impact factor: 11.951

9.  Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials.

Authors:  Marianne Canonico; Geneviève Plu-Bureau; Mary Jo O'Sullivan; Marcia L Stefanick; Barbara Cochrane; Pierre-Yves Scarabin; Joann E Manson
Journal:  Menopause       Date:  2014-03       Impact factor: 2.953

Review 10.  Exosomal biomarkers in Down syndrome and Alzheimer's disease.

Authors:  Eric D Hamlett; Aurélie Ledreux; Huntington Potter; Heidi J Chial; David Patterson; Joaquin M Espinosa; Brianne M Bettcher; Ann-Charlotte Granholm
Journal:  Free Radic Biol Med       Date:  2017-09-05       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.